Contact Us

Yes. p53 rescue experiments in HCT 116 are well-established in cancer biology research: • Construct design: use a codon-modified TP53 sequence with a small C-terminal tag (FLAG, HA). The N-terminal transactivation domain is critical — avoid large N-terminal modifications. • Hotspot mutation rescue: cancer-associated p53 mutations (R175H, R248W, R273H, R282W) enable genotype-function correlation in a colorectal cancer-relevant background. R175H/R282W are conformational mutants; R248W/R273H are DNA-contact mutants — these classes have distinct downstream consequences. • Transactivation-dead rescue: the L22Q/W23S mutation abolishes p53 transcriptional activity and serves as a control for transcription-dependent versus transcription-independent functions. • Expression level: p53 levels are tightly regulated; overexpression triggers stress responses that confound interpretation. Use inducible (Tet-On) systems calibrated to endogenous levels. HCT 116 transduces efficiently with lentivirus; the MSI-high background should be considered when comparing with microsatellite-stable colorectal lines.

The choice depends on whether you are studying p53's tumor suppressor functions in colorectal cancer biology or using p53 status as a variable in drug response research. The Knockout line is the standard tool for both — HCT 116 has long served as a foundational cancer cell line for p53 research, with the parental p53 wild-type and derivative p53-null variants forming one of the most extensively cited isogenic pairs in cancer biology. Overexpression is useful for rescue experiments and for studying p53 hotspot mutations in a colorectal cancer-relevant background. For colorectal cancer p53 research, the EDITGENE TP53 Knockout in HCT 116 is a workhorse research tool — the parental line's MSI-high status and well-characterized oncogenic mutation profile (KRAS G13D, PIK3CA H1047R) create a defined cancer-genetic context for studying p53 loss. Rescue with wild-type or hotspot mutant (R175H, R248W, R273H, R282W) p53 enables genotype-function correlation studies particularly relevant to colorectal cancer.

The choice depends on whether you are studying CMTM6's stabilizing function on endogenous PD-L1 or its sufficiency to enhance PD-L1 surface levels. The Knockout line is the standard tool for the former — removing CMTM6 destabilizes PD-L1 and reveals the protein's dependency on this regulator. Overexpression is more useful for asking whether elevating CMTM6 above endogenous levels can further stabilize PD-L1 or rescue PD-L1 surface expression in low-CMTM6 contexts. For checkpoint biology research, the EDITGENE Knockout line is generally the more informative model because A-375 endogenously expresses both CMTM6 and PD-L1 — the relevant biology is already running, and you are asking what happens when one component is removed. Combining KO with rescue is the gold standard: a clean rescue confirms PD-L1 destabilization is CMTM6-specific and not a clonal artifact.

Yes. CMTM6 is a membrane protein, which introduces specific considerations beyond standard rescue design: • Construct design: use a codon-modified CMTM6 coding sequence to avoid guide RNA re-targeting. C-terminal tags (HA, FLAG) are generally preferred for membrane proteins; N-terminal tags may interfere with signal peptide processing. • Subcellular localization control: confirm that exogenous CMTM6 traffics correctly to the plasma membrane by surface staining or membrane fractionation. Mislocalized CMTM6 will not rescue PD-L1 stabilization regardless of expression level. • Functional readout: rescue should restore PD-L1 surface expression — measured by flow cytometry under both basal and IFN-γ-induced conditions. Restoration of total cellular PD-L1 without surface recovery indicates trafficking failure. • Delivery method: A-375 transduces efficiently with lentivirus; stable polyclonal pools or single-cell clones are both viable. Clonal selection is recommended for quantitative PD-L1 readouts to minimize cell-to-cell expression variability. EDITGENE has validated this line's compatibility with standard lentiviral systems and antibiotic selection.

The choice depends on the experimental question. The Knockout line is appropriate for asking whether ZNF219 is required for transcriptional regulation at candidate targets or for specific gene expression programs. Overexpression is appropriate when asking whether forced ZNF219 expression is sufficient to activate or repress target loci, or when probing dose-dependent regulatory effects. For a transcription factor where the activation/repression mode is still being defined, the EDITGENE Knockout line provides the more interpretable starting point: it reveals which transcripts depend on endogenous ZNF219 without confounding effects from non-physiological expression levels. Pairing with rescue experiments — including domain-mutant constructs — is the most rigorous way to assign mechanism to specific protein features.

Yes. As a transcription factor, rescue experiments for ZNF219 require attention to nuclear localization and expression level: • Construct design: use a codon-modified ZNF219 coding sequence with a C-terminal tag (FLAG, HA). N-terminal tags should be avoided if they overlap with nuclear localization signals. • Nuclear localization control: confirm by immunofluorescence that exogenous ZNF219 localizes to the nucleus. Cytoplasmic mislocalization (often from tag interference or truncated constructs) will not rescue transcriptional regulatory phenotypes. • Expression level: ZNF219, like many transcription factors, can exhibit dose-dependent effects. Titrate using inducible systems (Tet-On) to approximate endogenous levels — overexpression artifacts can produce phenotypes opposite to those of loss-of-function. • Domain mutants: rescue with zinc finger DNA-binding mutants provides a critical control for assigning observed effects to ZNF219's transcriptional activity rather than non-DNA-binding functions. U2OS exhibits high transfection efficiency and stable lentiviral integration, with flat morphology that supports imaging-based localization validation.

The choice depends on whether you are asking what ZMYM3 normally contributes to chromatin regulation and DNA damage response, or whether elevated ZMYM3 levels are sufficient to alter these processes. The Knockout line is the appropriate tool for the former and is particularly informative in HAP1, where the near-haploid genome eliminates allelic compensation. Overexpression is more useful for testing sufficiency hypotheses or for studying the consequences of ZMYM3 elevation seen in certain pathological contexts. For ZMYM3 — where functional characterization is still active — the EDITGENE Knockout line in HAP1 offers the cleanest loss-of-function signal available, making it the more defensible primary tool. Rescue with wild-type or domain-mutant ZMYM3 then provides the most rigorous validation.

Yes, but HAP1's near-haploid genome introduces considerations that differ from standard rescue experiments in diploid lines: • Integration site sensitivity: in a near-haploid background, lentiviral integration site effects on expression are more pronounced because there is no second allele to buffer position effects. Generating multiple independent rescue clones is strongly recommended. • Diploidization caveat: HAP1 cells gradually diploidize during long-term culture, which can alter rescue interpretation. Confirm ploidy status by flow cytometry at the time of phenotypic assay. • Construct design: use a codon-modified ZMYM3 sequence with a C-terminal tag. ZMYM3 contains multiple MYM zinc fingers; rescue with individual domain deletion mutants is informative for assigning function to specific structural elements. • Functional readout: for DNA damage response phenotypes, rescue should restore both transcriptional changes and damage repair kinetics — discordance between the two suggests m6A-independent or chromatin-only functions. HAP1 tolerates lentiviral transduction, though transduction efficiency is moderate compared to common immortalized lines — increase MOI accordingly during rescue line generation.

The choice depends on the experimental question, and for ZEB1 the answer is more context-dependent than for most factors. The Knockout line is appropriate when asking whether ZEB1 is required for repression of E-cadherin and other epithelial junction genes — although in HEK293, endogenous ZEB1 levels are modest, so the magnitude of phenotypic change may be smaller than in epithelial cancer lines. Overexpression is the more standard tool for driving EMT phenotypes in HEK293 and for activating mesenchymal gene programs. For mechanistic dissection of ZEB1's regulatory logic — E-box binding, miR-200 circuit dynamics, co-repressor recruitment — the EDITGENE Knockout line in HEK293 provides a clean genetic background for reporter assays and rescue experiments. For phenotypic EMT studies, overexpression in HEK293 or work in endogenous-EMT cell lines (e.g., MDA-MB-231) is generally more appropriate.

Yes, and rescue experiments are particularly important for ZEB1 because of its dose-sensitive role in EMT: • Construct design: use a codon-modified ZEB1 sequence with a small C-terminal tag (FLAG, HA). Avoid large tags — ZEB1's multiple zinc fingers and homeodomain are sensitive to steric interference. • Expression level control: this is critical for ZEB1. Overexpression beyond endogenous levels can drive EMT independently of any rescue effect, confounding interpretation. Inducible systems (Tet-On) with titration to physiological levels are strongly recommended. • Domain mutant rescue: rescue with zinc finger DNA-binding mutants distinguishes ZEB1's transcriptional activity from protein-protein interaction functions. miR-200 binding site mutants in the 3' UTR can probe regulatory feedback. • Functional readout: rescue should restore E-cadherin repression and mesenchymal gene expression. If endogenous miR-200 levels in HEK293 are high, they may suppress exogenous ZEB1 — consider miR-200-resistant rescue constructs (mutated 3' UTR seed sites). HEK293's high transfection efficiency and stable lentiviral integration make it well-suited for ZEB1 rescue line generation.

The choice depends on the experimental question, but for ZBTB39 — where prior functional characterization is limited — the framing of the question itself often needs to come first. The Knockout line is the appropriate tool for unbiased discovery: identifying transcripts and pathways affected by ZBTB39 loss without prior assumptions about its function. Overexpression is more useful once candidate regulatory activities have been proposed, allowing tests of sufficiency at specific loci. For initial characterization of an understudied factor like ZBTB39, the EDITGENE Knockout line is the higher-value starting point — it generates the foundational data needed to guide subsequent overexpression experiments. Rescue with wild-type or BTB-domain mutant constructs then provides specificity controls and assigns function to structural domains.

Yes, and rescue experiments are particularly valuable for an understudied factor like ZBTB39 where specificity controls are essential: • Construct design: use a codon-modified ZBTB39 sequence with a C-terminal tag (FLAG, HA). Avoid N-terminal tags near the BTB domain — this region mediates protein-protein interactions critical to ZBTB39 function. • Domain mutant rescue: include both BTB domain mutants (disrupting co-repressor recruitment) and zinc finger DNA-binding mutants. For a factor with limited functional characterization, domain mutant rescues are often more informative than wild-type rescue alone — they help assign discovered phenotypes to specific protein activities. • Expression level: titrate to approximate endogenous levels using inducible systems. For poorly characterized transcription factors, overexpression artifacts are a particularly serious concern because reference data on physiological function is limited. • Functional readout: rescue should restore transcriptional changes identified in the discovery transcriptomics experiments. Discordance between wild-type and domain mutant rescue is often the most informative result for emerging factors. HEK293 supports stable lentiviral integration with high transduction efficiency, making it well-suited for generating panels of rescue sublines.

The choice depends on whether you are asking what m6A-marked transcripts depend on YTHDF2-mediated decay, or whether forced YTHDF2 expression is sufficient to accelerate the degradation of candidate transcripts. The Knockout line reveals which transcripts stabilize when YTHDF2 is absent — the central question in YTHDF2 biology. Overexpression is more useful for testing sufficiency or for dissecting paralog competition with YTHDF1 and YTHDF3. For m6A-mediated decay research, the EDITGENE Knockout line is generally the more informative tool because YTHDF family proteins have overlapping functions, and overexpression of one paralog can be confounded by displacement of others. Rescue with wild-type or m6A-binding-defective (W432A) YTHDF2 is the standard specificity control for assigning phenotypes to m6A reader activity.

Yes. YTHDF2 rescue experiments have a well-established specificity control framework due to the maturity of m6A reader research: • Construct design: use a codon-modified YTHDF2 sequence with a C-terminal tag (FLAG, HA). Both N- and C-terminal tags are generally tolerated for YTH family proteins. • m6A-binding-defective rescue: the W432A mutation in the YTH domain abolishes m6A binding and is the standard specificity control for assigning phenotypes to m6A reader activity. Rescue with wild-type but not W432A YTHDF2 confirms m6A-dependent function. • Paralog considerations: YTHDF1 and YTHDF3 share substantial sequence similarity and overlapping target transcripts with YTHDF2. If studying transcript-specific effects, consider whether observed phenotypes might reflect paralog redundancy rather than YTHDF2-specific function. • Functional readout: rescue should restore m6A-modified transcript decay rates (measured by mRNA half-life assays for candidate targets) and accompanying phenotypic outputs in HCT 116. HCT 116 transduces efficiently with lentivirus and supports both polyclonal and clonal rescue line generation.

The choice depends on the experimental question, and YTHDC1's multifunctional nature makes this distinction particularly important. The Knockout line is appropriate for asking whether YTHDC1 is required for pre-mRNA splicing, nuclear export of m6A transcripts, p53 response, or ferroptosis sensitivity — all functions characterized in A-549. Overexpression is useful for testing sufficiency hypotheses or for studying YTHDC1 condensate formation, which is concentration-dependent. For most YTHDC1 research questions in lung cancer biology, the EDITGENE Knockout line is the more informative tool — particularly because published YTHDC1 functional data in A-549 (p53 reporter screens, ferroptosis assays, FSP1 splicing) was generated in the loss-of-function context. Rescue with wild-type or m6A-binding-defective YTHDC1 is essential for assigning observed phenotypes to m6A reader activity versus m6A-independent functions, which have been reported for p53 regulation.